Bioabsorbable Stents Market – Global Industry Analysis and Forecast (2023-2029)


Global Bioabsorbable Stents Market size is expected to reach US$ 532.02 Mn. by year 2029 at a CAGR of 7.35% during the forecast period.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.Bioabsorbable Stents MarketTo know about the Research Methodology:-Request Free Sample Report

Global Bioabsorbable Stents Market Dynamics:

The bioabsorbable stents are the devices inserted into the blood vessel and other internal vessels to check a blockage. These stents are made up of materials may be absorbed or dissolved in the body.

The major driving factors of the global market are increasing in the incidence of cardiac diseases, the risk of coronary artery & peripheral artery diseases in the elderly population, and number of heart failure and diabetes cases. Additionally, strong product pipelines, rising technological advancements, and increasing diabetic population also drives the market growth. Rising demand from emerging economies as well as high-risk patients is a key opportunity for bioabsorbable stents market growth. Further, rising healthcare expenditure in the emerging countries are also a major opportunity for bioabsorbable stents market.

Some challenges of the global market are the availability of substitute, increasing R&D activities for the cell transplantation to treat the heart, a stringent guideline for authorization of devices, and growing competition among vendors. Slow adoption rate, stringent government regulations, and the high cost of devices are hampering the global bioabsorbable stents market growth.

The  market is segmented into absorption rates, drugs, applications, end users, materials, and region. The bio absorbable stents market based on absorption rates includes slow absorption stents and fast absorption stents. In terms of the drugs, the market is classified into paclitaxel, and limus based drugs. Based on the bioabsorbable stents market, applications segment is divided into coronary artery disease and peripheral artery disease.

Global Market Regional Analysis:

In terms of an end users,market is categorized into hospitals and cardiac centers. Further, bioabsorbable stents market based on materials includes polymeric stents and metallic stents. Based on regions, the global market is divided into five main regions are America, Europe, Asia-pacific, Latin America and Middle East & Africa. By end use, the hospital segment dominated the market during in terms of revenue and will continue to lead until the end of the forecast period due to the advanced medical infrastructure and trained professionals to cater to the needs of people, which are not usually seen in cardiac centers and small clinics.

In terms of material, polymeric bioabsorbable stents are widely used in cardiovascular devices. Polymers used in bioabsorbable stents are Poly-L-Lactic acid, Poly copolymer, Polyglycolic Acid, and polycaprolactone. Polymeric stents market is anticipated to grow at a faster rate. Usage of bioabsorbable polymer coating reduces the need for extended dual antiplatelet therapy and reduces thrombotic events. Poly-L-Lactic acid is widely used in medicine and breaks down lactic acid into natural metabolites in the human body.

Based on application, the coronary artery diseases accounted for xx % largest share of the market, due to the increasing population prone to coronary artery diseases and the adoption of unhealthy lifestyle habits leading to increased risk of these diseases.

Geographically, The Asia-Pacific market is anticipated to the fastest-growing region for the bioabsorbable stent market, due to the growing population of the geriatric people as well as the increasing awareness among people about the procedure and the products in the region. Rapidly developing healthcare infrastructure, medical tourism, and a growing geriatric population is some of the major factors that are driving the growth of the bioabsorbable stents market in the region.

The objective of the report is to present comprehensive analysis of Global Bioabsorbable Stents Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global market dynamics, structure by analyzing the market segments, and project the Global  Market size. Clear representation of competitive analysis of key players by Global Bioabsorbable Stents type, price, financial position, product portfolio, growth strategies, and regional presence in the Global market make the report investor’s guide.

Global Bioabsorbable Stents Market, Key Highlights:

Global market analysis and forecast, in terms of value.

Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Bioabsorbable Stents Market

Global market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

Bioabsorbable Stents Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

Global Bioabsorbable Stents Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Bioabsorbable Stents Market are also profiled.

Global Bioabsorbable Stents Market Scope: Inquire before buying






Global Bioabsorbable Stents Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 323.82 Mn.




Forecast Period 2023 to 2029 CAGR:
7.35%
Market Size in 2029:
US $ 532.02 Mn.




 Segments Covered:
by Absorption rates
Slow absorption stents
Fast absorption stents




by Drugs
Paclitaxel
Limus based drugs




by Applications
Coronary artery disease
Peripheral artery disease




by End-Users
Hospitals
Cardiac centers




by Materials
Polymeric Stents
Metallic Stents






Global Bioabsorbable Stents Market, by Region:

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Global Bioabsorbable Stents Market Key Players

1. 480 Biomedical
2. Abbott
3. Amaranth Medical Inc.
4. Arterial Remodeling Technologies
5. Arterius Limited
6. BIOTRONIK
7. Boston Scientific Corporation
8. Elixir Medical Corporation
9. HangZhou HuaAn Biotechnology Co., Ltd
10. KYOTO MEDICAL PLANNING Co. Ltd.
11. LEPU MEDICAL TECHNOLOGY CO. LTD.
12. Lifetech Scientific (Shenzhen) Co. Ltd
13. Manli Cardiology Ltd.
14. Meril Life Sciences Pvt. Ltd.
15. ORBUSNEICH
16. QualiMed
17. REVA Medical Inc.
18. S3V Vascular Technologies
19. SMT
20. TEPHA INC
21. Zorion Medical Inc

Frequently Asked Questions:

1. Which region has the largest share in Global Bioabsorbable Stents Market?
Ans: Asia Pacific region holds the highest share in 2022.

2. What is the growth rate of Global Bioabsorbable Stents Market?
Ans: The Global Bioabsorbable Stents Market is growing at a CAGR of 7.35% during forecasting period 2023-2029.

3. What is scope of the Global Bioabsorbable Stents market report?
Ans: Global Bioabsorbable Stents Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Bioabsorbable Stents market?
Ans: The important key players in the Global Bioabsorbable Stents Market are – 480 Biomedical, Abbott, Amaranth Medical Inc., Arterial Remodeling Technologies, Arterius Limited, BIOTRONIK, Boston Scientific Corporation, Elixir Medical Corporation, HangZhou HuaAn Biotechnology Co., Ltd, KYOTO MEDICAL PLANNING Co. Ltd., LEPU MEDICAL TECHNOLOGY CO. LTD., Lifetech Scientific (Shenzhen) Co. Ltd, Manli Cardiology Ltd., Meril Life Sciences Pvt. Ltd., ORBUSNEICH, QualiMed, REVA Medical Inc., S3V Vascular Technologies, SMT, TEPHA INC, and Zorion Medical Inc

5. What is the study period of this market?
Ans: The Global Bioabsorbable Stents Market is studied from 2022 to 2029. 





Global Bioabsorbable Stents Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
1.4. Key Questions Answered

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations Used
2.3. Research Methodology

3. Executive Summary
3.1. Global Bioabsorbable Stents Market Size, by Market Value (US$ Mn) and Market, by Region

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Porter’s Analysis
4.3.5. Value Chain Analysis
4.3.6. SWOT Analysis
4.4. Global Bioabsorbable Stents Market Industry Trends

5. Global Bioabsorbable Stents Market Analysis and Forecast
5.1. Global Bioabsorbable Stents Market Analysis and Forecast
5.2. Global Bioabsorbable Stents Market Size & Y-o-Y Growth Analysis
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Middle East & Africa
5.2.5. Latin America

6. Global Bioabsorbable Stents Market Analysis and Forecast, by Absorption rates
6.1. Introduction and Definition
6.2. Key Findings
6.3. Global Bioabsorbable Stents Market Value Share Analysis, by Absorption rates
6.4. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by Absorption rates
6.5. Global Bioabsorbable Stents Market Analysis, by Absorption rates
6.6. Global Bioabsorbable Stents Market Attractiveness Analysis, by Absorption rates

7. Global Bioabsorbable Stents Market Analysis and Forecast, by Drugs
7.1. Introduction and Definition
7.2. Global Bioabsorbable Stents Market Value Share Analysis, by Drugs
7.3. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by Drugs
7.4. Global Bioabsorbable Stents Market Analysis, by Drugs
7.5. Global Bioabsorbable Stents Market Attractiveness Analysis, by Drugs

8. Global Bioabsorbable Stents Market Analysis and Forecast, by Applications
8.1. Introduction and Definition
8.2. Global Bioabsorbable Stents Market Value Share Analysis, by Applications
8.3. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by Applications
8.4. Global Bioabsorbable Stents Market Analysis, by Applications
8.5. Global Bioabsorbable Stents Market Attractiveness Analysis, by Applications

9. Global Bioabsorbable Stents Market Analysis and Forecast, by End user
9.1. Introduction and Definition
9.2. Global Bioabsorbable Stents Market Value Share Analysis, by End user
9.3. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by End user
9.4. Global Bioabsorbable Stents Market Analysis, by End user
9.5. Global Bioabsorbable Stents Market Attractiveness Analysis, by End user

10. Global Bioabsorbable Stents Market Analysis and Forecast, by Materials
10.1. Introduction and Definition
10.2. Global Bioabsorbable Stents Market Value Share Analysis, by Materials
10.3. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by Materials
10.4. Global Bioabsorbable Stents Market Analysis, by Materials
10.5. Global Bioabsorbable Stents Market Attractiveness Analysis, by Materials

11. Global Bioabsorbable Stents Market Analysis, by Region
11.1. Global Bioabsorbable Stents Market Value Share Analysis, by Region
11.2. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by Region
11.3. Global Bioabsorbable Stents Market Attractiveness Analysis, by Region

12. North America Bioabsorbable Stents Market Analysis
12.1. Key Findings
12.2. North America Bioabsorbable Stents Market Overview
12.3. North America Bioabsorbable Stents Market Value Share Analysis, by Absorption rates
12.4. North America Bioabsorbable Stents Market Forecast, by Absorption rates
12.4.1. Slow absorption stents
12.4.2. Fast absorption stents
12.5. North America Bioabsorbable Stents Market Value Share Analysis, by Drugs
12.6. North America Bioabsorbable Stents Market Forecast, by Drugs
12.6.1. Paclitaxel
12.6.2. Limus based drugs
12.7. North America Bioabsorbable Stents Market Value Share Analysis, by Applications
12.8. North America Bioabsorbable Stents Market Forecast, by Applications
12.8.1. Coronary artery disease
12.8.2. Peripheral artery disease
12.9. North America Bioabsorbable Stents Market Value Share Analysis, by End user
12.10. North America Bioabsorbable Stents Market Forecast, by End user
12.10.1. Hospitals
12.10.2. Cardiac centers
12.11. North America Bioabsorbable Stents Market Value Share Analysis, by Materials
12.12. North America Bioabsorbable Stents Market Forecast, by Materials
12.12.1. Polymeric Stents
12.12.2. Metallic Stents
12.13. North America Bioabsorbable Stents Market Value Share Analysis, by Country
12.14. North America Bioabsorbable Stents Market Forecast, by Country
12.14.1. U.S.
12.14.2. Canada
12.15. North America Bioabsorbable Stents Market Analysis, by Country
12.16. U.S. Bioabsorbable Stents Market Forecast, by Absorption rates
12.16.1. Slow absorption stents
12.16.2. Fast absorption stents
12.17. U.S. Bioabsorbable Stents Market Forecast, by Drugs
12.17.1. Paclitaxel
12.17.2. Limus based drugs
12.18. U.S. Bioabsorbable Stents Market Forecast, by Applications
12.18.1. Coronary artery disease
12.18.2. Peripheral artery disease
12.19. U.S. Bioabsorbable Stents Market Forecast, by End user
12.19.1. Hospitals
12.19.2. Cardiac centers
12.20. U.S. Bioabsorbable Stents Market Forecast, by Materials
12.20.1. Polymeric Stents
12.20.2. Metallic Stents
12.21. Canada Bioabsorbable Stents Market Forecast, by Absorption rates
12.21.1. Slow absorption stents
12.21.2. Fast absorption stents
12.22. Canada Bioabsorbable Stents Market Forecast, by Drugs
12.22.1. Paclitaxel
12.22.2. Limus based drugs
12.23. Canada Bioabsorbable Stents Market Forecast, by Applications
12.23.1. Coronary artery disease
12.23.2. Peripheral artery disease
12.24. Canada Bioabsorbable Stents Market Forecast, by End user
12.24.1. Hospitals
12.24.2. Cardiac centers
12.25. Canada Bioabsorbable Stents Market Forecast, by Materials
12.25.1. Polymeric Stents
12.25.2. Metallic Stents
12.26. North America Bioabsorbable Stents Market Attractiveness Analysis
12.26.1. By Absorption rates
12.26.2. By Drugs
12.26.3. By Applications
12.26.4. By End user
12.26.5. By Materials
12.27. PEST Analysis

13. Europe Bioabsorbable Stents Market Analysis
13.1. Key Findings
13.2. Europe Bioabsorbable Stents Market Overview
13.3. Europe Bioabsorbable Stents Market Value Share Analysis, by Absorption rates
13.4. Europe Bioabsorbable Stents Market Forecast, by Absorption rates
13.4.1. Slow absorption stents
13.4.2. Fast absorption stents
13.5. Europe Bioabsorbable Stents Market Value Share Analysis, by Drugs
13.6. Europe Bioabsorbable Stents Market Forecast, by Drugs
13.6.1. Paclitaxel
13.6.2. Limus based drugs
13.7. Europe Bioabsorbable Stents Market Value Share Analysis, by Applications
13.8. Europe Bioabsorbable Stents Market Forecast, by Applications
13.8.1. Coronary artery disease
13.8.2. Peripheral artery disease
13.9. Europe Bioabsorbable Stents Market Value Share Analysis, by End user
13.10. Europe Bioabsorbable Stents Market Forecast, by End user
13.10.1. Hospitals
13.10.2. Cardiac centers
13.11. Europe Bioabsorbable Stents Market Value Share Analysis, by Materials
13.12. Europe Bioabsorbable Stents Market Forecast, by Materials
13.12.1. Polymeric Stents
13.12.2. Metallic Stents
13.13. Europe Bioabsorbable Stents Market Value Share Analysis, by Country
13.14. Europe Bioabsorbable Stents Market Forecast, by Country
13.14.1. Germany
13.14.2. U.K.
13.14.3. France
13.14.4. Italy
13.14.5. Spain
13.14.6. Rest of Europe
13.15. Europe Bioabsorbable Stents Market Analysis, by Country/ Sub-region
13.16. Germany Bioabsorbable Stents Market Forecast, by Absorption rates
13.16.1. Slow absorption stents
13.16.2. Fast absorption stents
13.17. Germany Bioabsorbable Stents Market Forecast, by Drugs
13.17.1. Paclitaxel
13.17.2. Limus based drugs
13.18. Germany Bioabsorbable Stents Market Forecast, by Applications
13.18.1. Coronary artery disease
13.18.2. Peripheral artery disease
13.19. Germany Bioabsorbable Stents Market Forecast, by End user
13.19.1. Hospitals
13.19.2. Cardiac centers
13.20. Germany Bioabsorbable Stents Market Forecast, by Materials
13.20.1. Polymeric Stents
13.20.2. Metallic Stents
13.21. U.K. Bioabsorbable Stents Market Forecast, by Absorption rates
13.21.1. Slow absorption stents
13.21.2. Fast absorption stents
13.22. U.K. Bioabsorbable Stents Market Forecast, by Drugs
13.22.1. Paclitaxel
13.22.2. Limus based drugs
13.23. U.K. Bioabsorbable Stents Market Forecast, by Applications
13.23.1. Coronary artery disease
13.23.2. Peripheral artery disease
13.24. U.K. Bioabsorbable Stents Market Forecast, by End user
13.24.1. Hospitals
13.24.2. Cardiac centers
13.25. U.K. Bioabsorbable Stents Market Forecast, by Materials
13.25.1. Polymeric Stents
13.25.2. Metallic Stents
13.26. France Bioabsorbable Stents Market Forecast, by Absorption rates
13.26.1. Slow absorption stents
13.26.2. Fast absorption stents
13.27. France Bioabsorbable Stents Market Forecast, by Drugs
13.27.1. Paclitaxel
13.27.2. Limus based drugs
13.28. France Bioabsorbable Stents Market Forecast, by Applications
13.28.1. Coronary artery disease
13.28.2. Peripheral artery disease
13.29. France Bioabsorbable Stents Market Forecast, by End user
13.29.1. Hospitals
13.29.2. Cardiac centers
13.30. France Bioabsorbable Stents Market Forecast, by Materials
13.30.1. Polymeric Stents
13.30.2. Metallic Stents
13.31. Italy Bioabsorbable Stents Market Forecast, by Absorption rates
13.31.1. Slow absorption stents
13.31.2. Fast absorption stents
13.32. Italy Bioabsorbable Stents Market Forecast, by Drugs
13.32.1. Paclitaxel
13.32.2. Limus based drugs
13.33. Italy Bioabsorbable Stents Market Forecast, by Applications
13.33.1. Coronary artery disease
13.33.2. Peripheral artery disease
13.34. Italy Bioabsorbable Stents Market Forecast, by End user
13.34.1. Hospitals
13.34.2. Cardiac centers
13.35. Italy Bioabsorbable Stents Market Forecast, by Materials
13.35.1. Polymeric Stents
13.35.2. Metallic Stents
13.36. Spain Bioabsorbable Stents Market Forecast, by Absorption rates
13.36.1. Slow absorption stents
13.36.2. Fast absorption stents
13.37. Spain Bioabsorbable Stents Market Forecast, by Drugs
13.37.1. Paclitaxel
13.37.2. Limus based drugs
13.38. Spain Bioabsorbable Stents Market Forecast, by Applications
13.38.1. Coronary artery disease
13.38.2. Peripheral artery disease
13.39. Spain Bioabsorbable Stents Market Forecast, by End user
13.39.1. Hospitals
13.39.2. Cardiac centers
13.40. Spain Bioabsorbable Stents Market Forecast, by Materials
13.40.1. Polymeric Stents
13.40.2. Metallic Stents
13.41. Rest of Europe Bioabsorbable Stents Market Forecast, by Absorption rates
13.41.1. Slow absorption stents
13.41.2. Fast absorption stents
13.42. Rest of Europe Bioabsorbable Stents Market Forecast, by Drugs
13.42.1. Paclitaxel
13.42.2. Limus based drugs
13.43. Rest of Europe Bioabsorbable Stents Market Forecast, by Applications
13.43.1. Coronary artery disease
13.43.2. Peripheral artery disease
13.44. Rest Of Europe Bioabsorbable Stents Market Forecast, by End user
13.44.1. Hospitals
13.44.2. Cardiac centers
13.45. Rest Of Europe Bioabsorbable Stents Market Forecast, by Materials
13.45.1. Polymeric Stents
13.45.2. Metallic Stents
13.46. Europe Bioabsorbable Stents Market Attractiveness Analysis
13.46.1. By Absorption rates
13.46.2. By Drugs
13.46.3. By Applications
13.46.4. By End user
13.46.5. By Materials
13.47. PEST Analysis

14. Asia Pacific Bioabsorbable Stents Market Analysis
14.1. Key Findings
14.2. Asia Pacific Bioabsorbable Stents Market Overview
14.3. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Absorption rates
14.4. Asia Pacific Bioabsorbable Stents Market Forecast, by Absorption rates
14.4.1. Slow absorption stents
14.4.2. Fast absorption stents
14.5. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Drugs
14.6. Asia Pacific Bioabsorbable Stents Market Forecast, by Drugs
14.6.1. Paclitaxel
14.6.2. Limus based drugs
14.7. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Applications
14.8. Asia Pacific Bioabsorbable Stents Market Forecast, by Applications
14.8.1. Coronary artery disease
14.8.2. Peripheral artery disease
14.9. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by End user
14.10. Asia Pacific Bioabsorbable Stents Market Forecast, by End user
14.10.1. Hospitals
14.10.2. Cardiac centers
14.11. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Materials
14.12. Asia Pacific Bioabsorbable Stents Market Forecast, by Materials
14.12.1. Polymeric Stents
14.12.2. Metallic Stents
14.13. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Country
14.14. Asia Pacific Bioabsorbable Stents Market Forecast, by Country
14.14.1. China
14.14.2. India
14.14.3. Japan
14.14.4. ASEAN
14.14.5. Rest of Asia Pacific
14.15. Asia Pacific Bioabsorbable Stents Market Analysis, by Country/ Sub-region
14.16. China Bioabsorbable Stents Market Forecast, by Absorption rates
14.16.1. Slow absorption stents
14.16.2. Fast absorption stents
14.17. China Bioabsorbable Stents Market Forecast, by Drugs
14.17.1. Paclitaxel
14.17.2. Limus based drugs
14.18. China Bioabsorbable Stents Market Forecast, by Applications
14.18.1. Coronary artery disease
14.18.2. Peripheral artery disease
14.19. China Bioabsorbable Stents Market Forecast, by End user
14.19.1. Hospitals
14.19.2. Cardiac centers
14.20. China Bioabsorbable Stents Market Forecast, by Materials
14.20.1. Polymeric Stents
14.20.2. Metallic Stents
14.21. India Bioabsorbable Stents Market Forecast, by Absorption rates
14.21.1. Slow absorption stents
14.21.2. Fast absorption stents
14.22. India Bioabsorbable Stents Market Forecast, by Drugs
14.22.1. Paclitaxel
14.22.2. Limus based drugs
14.23. India Bioabsorbable Stents Market Forecast, by Applications
14.23.1. Coronary artery disease
14.23.2. Peripheral artery disease
14.24. India Bioabsorbable Stents Market Forecast, by End user
14.24.1. Hospitals
14.24.2. Cardiac centers
14.25. India Bioabsorbable Stents Market Forecast, by Materials
14.25.1. Polymeric Stents
14.25.2. Metallic Stents
14.26. Japan Bioabsorbable Stents Market Forecast, by Absorption rates
14.26.1. Slow absorption stents
14.26.2. Fast absorption stents
14.27. Japan Bioabsorbable Stents Market Forecast, by Drugs
14.27.1. Paclitaxel
14.27.2. Limus based drugs
14.28. Japan Bioabsorbable Stents Market Forecast, by Applications
14.28.1. Coronary artery disease
14.28.2. Peripheral artery disease
14.29. Japan Bioabsorbable Stents Market Forecast, by End user
14.29.1. Hospitals
14.29.2. Cardiac centers
14.30. Japan Bioabsorbable Stents Market Forecast, by Materials
14.30.1. Polymeric Stents
14.30.2. Metallic Stents
14.31. ASEAN Bioabsorbable Stents Market Forecast, by Absorption rates
14.31.1. Slow absorption stents
14.31.2. Fast absorption stents
14.32. ASEAN Bioabsorbable Stents Market Forecast, by Drugs
14.32.1. Paclitaxel
14.32.2. Limus based drugs
14.33. ASEAN Bioabsorbable Stents Market Forecast, by Applications
14.33.1. Coronary artery disease
14.33.2. Peripheral artery disease
14.34. ASEAN Bioabsorbable Stents Market Forecast, by End user
14.34.1. Hospitals
14.34.2. Cardiac centers
14.35. ASEAN Bioabsorbable Stents Market Forecast, by Materials
14.35.1. Polymeric Stents
14.35.2. Metallic Stents
14.36. Rest of Asia Pacific Bioabsorbable Stents Market Forecast, by Absorption rates
14.36.1. Slow absorption stents
14.36.2. Fast absorption stents
14.37. Rest of Asia Pacific Bioabsorbable Stents Market Forecast, by Drugs
14.37.1. Paclitaxel
14.37.2. Limus based drugs
14.38. Rest of Asia Pacific Bioabsorbable Stents Market Forecast, by Applications
14.38.1. Coronary artery disease
14.38.2. Peripheral artery disease
14.39. Rest of Asia Pacific Bioabsorbable Stents Market Forecast, by End user
14.39.1. Hospitals
14.39.2. Cardiac centers
14.40. Rest of Asia Pacific Bioabsorbable Stents Market Forecast, by Materials
14.40.1. Polymeric Stents
14.40.2. Metallic Stents
14.41. Asia Pacific Bioabsorbable Stents Market Attractiveness Analysis
14.41.1. By Absorption rates
14.41.2. By Drugs
14.41.3. By Applications
14.41.4. By End user
14.41.5. By Materials
14.42. PEST Analysis

15. Middle East & Africa Bioabsorbable Stents Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Bioabsorbable Stents Market Overview
15.3. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Absorption rates
15.4. Middle East & Africa Bioabsorbable Stents Market Forecast, by Absorption rates
15.4.1. Slow absorption stents
15.4.2. Fast absorption stents
15.5. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Drugs
15.6. Middle East & Africa Bioabsorbable Stents Market Forecast, by Drugs
15.6.1. Paclitaxel
15.6.2. Limus based drugs
15.7. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Applications
15.8. Middle East & Africa Bioabsorbable Stents Market Forecast, by Applications
15.8.1. Coronary artery disease
15.8.2. Peripheral artery disease
15.9. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by End user
15.10. Middle East & Africa Bioabsorbable Stents Market Forecast, by End user
15.10.1. Hospitals
15.10.2. Cardiac centers
15.11. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Materials
15.12. Middle East & Africa Bioabsorbable Stents Market Forecast, by Materials
15.12.1. Polymeric Stents
15.12.2. Metallic Stents
15.13. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Country
15.14. Middle East & Africa Bioabsorbable Stents Market Forecast, by Country
15.14.1. GCC
15.14.2. South Africa
15.14.3. Rest of Middle East & Africa
15.15. Middle East & Africa Bioabsorbable Stents Market Analysis, by Country/ Sub-region
15.16. GCC Bioabsorbable Stents Market Forecast, by Absorption rates
15.16.1. Slow absorption stents
15.16.2. Fast absorption stents
15.17. GCC Bioabsorbable Stents Market Forecast, by Drugs
15.17.1. Paclitaxel
15.17.2. Limus based drugs
15.18. GCC Bioabsorbable Stents Market Forecast, by Applications
15.18.1. Coronary artery disease
15.18.2. Peripheral artery disease
15.19. GCC Bioabsorbable Stents Market Forecast, by End user
15.19.1. Hospitals
15.19.2. Cardiac centers
15.20. GCC Bioabsorbable Stents Market Forecast, by Materials
15.20.1. Polymeric Stents
15.20.2. Metallic Stents
15.21. South Africa Bioabsorbable Stents Market Forecast, by Absorption rates
15.21.1. Slow absorption stents
15.21.2. Fast absorption stents
15.22. South Africa Bioabsorbable Stents Market Forecast, by Drugs
15.22.1. Paclitaxel
15.22.2. Limus based drugs
15.23. South Africa Bioabsorbable Stents Market Forecast, by Applications
15.23.1. Coronary artery disease
15.23.2. Peripheral artery disease
15.24. South Africa Bioabsorbable Stents Market Forecast, by End user
15.24.1. Hospitals
15.24.2. Cardiac centers
15.25. South Africa Bioabsorbable Stents Market Forecast, by Materials
15.25.1. Polymeric Stents
15.25.2. Metallic Stents
15.26. Rest of Middle East & Africa Bioabsorbable Stents Market Forecast, by Absorption rates
15.26.1. Slow absorption stents
15.26.2. Fast absorption stents
15.27. Rest of Middle East & Africa Bioabsorbable Stents Market Forecast, by Drugs
15.27.1. Paclitaxel
15.27.2. Limus based drugs
15.28. Rest of Middle East & Africa Bioabsorbable Stents Market Forecast, by Applications
15.28.1. Coronary artery disease
15.28.2. Peripheral artery disease
15.29. Rest of Middle East & Africa Bioabsorbable Stents Market Forecast, by End user
15.29.1. Hospitals
15.29.2. Cardiac centers
15.30. Rest of Middle East & Africa Bioabsorbable Stents Market Forecast, by Materials
15.30.1. Polymeric Stents
15.30.2. Metallic Stents
15.31. Middle East & Africa Bioabsorbable Stents Market Attractiveness Analysis
15.31.1. By Absorption rates
15.31.2. By Drugs
15.31.3. By Applications
15.31.4. By End user
15.31.5. By Materials
15.32. PEST Analysis

16. Latin America Bioabsorbable Stents Market Analysis
16.1. Key Findings
16.2. Latin America Bioabsorbable Stents Market Overview
16.3. Latin America Bioabsorbable Stents Market Value Share Analysis, by Absorption rates
16.4. Latin America Bioabsorbable Stents Market Forecast, by Absorption rates
16.4.1. Slow absorption stents
16.4.2. Fast absorption stents
16.5. Latin America Bioabsorbable Stents Market Value Share Analysis, by Drugs
16.6. Latin America Bioabsorbable Stents Market Forecast, by Drugs
16.6.1. Paclitaxel
16.6.2. Limus based drugs
16.7. Latin America Bioabsorbable Stents Market Value Share Analysis, by Applications
16.8. Latin America Bioabsorbable Stents Market Forecast, by Applications
16.8.1. Coronary artery disease
16.8.2. Peripheral artery disease
16.9. Latin America Bioabsorbable Stents Market Value Share Analysis, by End user
16.10. Latin America Bioabsorbable Stents Market Forecast, by End user
16.10.1. Hospitals
16.10.2. Cardiac centers
16.11. Latin America Bioabsorbable Stents Market Value Share Analysis, by Materials
16.12. Latin America Bioabsorbable Stents Market Forecast, by Materials
16.12.1. Polymeric Stents
16.12.2. Metallic Stents
16.13. Latin America Bioabsorbable Stents Market Value Share Analysis, by Country
16.14. Latin America Bioabsorbable Stents Market Forecast, by Country
16.14.1. Brazil
16.14.2. Mexico
16.14.3. Rest of Latin America
16.15. Latin America Bioabsorbable Stents Market Analysis, by Country/ Sub-region
16.16. Brazil Bioabsorbable Stents Market Forecast, by Absorption rates
16.16.1. Slow absorption stents
16.16.2. Fast absorption stents
16.17. Brazil Bioabsorbable Stents Market Forecast, by Drugs
16.17.1. Paclitaxel
16.17.2. Limus based drugs
16.18. Brazil Bioabsorbable Stents Market Forecast, by Applications
16.18.1. Coronary artery disease
16.18.2. Peripheral artery disease
16.19. Brazil Bioabsorbable Stents Market Forecast, by End user
16.19.1. Hospitals
16.19.2. Cardiac centers
16.20. Brazil Bioabsorbable Stents Market Forecast, by Materials
16.20.1. Polymeric Stents
16.20.2. Metallic Stents
16.21. Mexico Bioabsorbable Stents Market Forecast, by Absorption rates
16.21.1. Slow absorption stents
16.21.2. Fast absorption stents
16.22. Mexico Bioabsorbable Stents Market Forecast, by Drugs
16.22.1. Paclitaxel
16.22.2. Limus based drugs
16.23. Mexico Bioabsorbable Stents Market Forecast, by Applications
16.23.1. Coronary artery disease
16.23.2. Peripheral artery disease
16.24. Mexico Bioabsorbable Stents Market Forecast, by End user
16.24.1. Hospitals
16.24.2. Cardiac centers
16.25. Mexico Bioabsorbable Stents Market Forecast, by Materials
16.25.1. Polymeric Stents
16.25.2. Metallic Stents
16.26. Rest of Latin America Bioabsorbable Stents Market Forecast, by Absorption rates
16.26.1. Slow absorption stents
16.26.2. Fast absorption stents
16.27. Rest of Latin America Bioabsorbable Stents Market Forecast, by Drugs
16.27.1. Paclitaxel
16.27.2. Limus based drugs
16.28. Rest of Latin America Bioabsorbable Stents Market Forecast, by Applications
16.28.1. Coronary artery disease
16.28.2. Peripheral artery disease
16.29. Rest of Latin America Bioabsorbable Stents Market Forecast, by End user
16.29.1. Hospitals
16.29.2. Cardiac centers
16.30. Rest of Latin America Bioabsorbable Stents Market Forecast, by Materials
16.30.1. Polymeric Stents
16.30.2. Metallic Stents
16.31. Latin America Bioabsorbable Stents Market Attractiveness Analysis
16.31.1. By Absorption rates
16.31.2. By Drugs
16.31.3. By Applications
16.31.4. By End users
16.31.5. By Materials
16.32. PEST Analysis

17. Company Profiles
17.1. Market Share Analysis, by Company
17.2. Competition Matrix
17.3. Company Profiles: Key Players
17.3.1. SMT
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Business Strategy
17.3.1.4. Recent Developments
17.3.1.5. Manufacturing Footprint
17.3.2. 480 Biomedical
17.3.3. Abbott
17.3.4. Amaranth Medical Inc.
17.3.5. Arterial Remodeling Technologies
17.3.6. Arterius Limited
17.3.7. BIOTRONIK
17.3.8. Boston Scientific Corporation
17.3.9. Elixir Medical Corporation
17.3.10. HangZhou HuaAn Biotechnology Co.,Ltd
17.3.11. KYOTO MEDICAL PLANNING Co. Ltd.
17.3.12. LEPU MEDICAL TECHNOLOGY CO. LTD.
17.3.13. Lifetech Scientific (Shenzhen) Co. Ltd
17.3.14. Manli Cardiology Ltd.
17.3.15. Meril Life Sciences Pvt. Ltd.
17.3.16. ORBUSNEICH
17.3.17. QualiMed
17.3.18. REVA Medical Inc.
17.3.19. S3V Vascular Technologies
17.3.20. TEPHA INC
17.3.21. Zorion Medical Inc

18. Primary Key Insights
  • INQUIRE BEFORE BUYING